The high eIF3D expression group had a significantly larger ratio of patients with residual tumour (13/4 vs. 163/176, p = 0.0257) and targeted molecular therapy (85/65 vs. 138/164, p = 0.0357). Here, EIF3D is linked to neoplasm.